Avanos Medical Inc (AVNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 177,800 | 175,000 | 167,500 | 179,600 | 170,400 |
| Cost of Goods | 91,800 | 82,900 | 77,700 | 81,600 | 77,500 |
| Gross Profit | 86,000 | 92,100 | 89,800 | 98,000 | 92,900 |
| Operating Expenses | 86,700 | 167,500 | 80,200 | 517,100 | 81,400 |
| Operating Income | 100 | -74,500 | 10,300 | -418,500 | 12,000 |
| Interest Expense | 1,800 | 2,000 | 2,100 | 2,800 | 3,200 |
| Other Income | 500 | 600 | 1,500 | 800 | 700 |
| Pre-tax Income | -1,200 | -75,900 | 9,700 | -420,500 | 9,500 |
| Income Tax | 200 | 900 | 3,100 | -23,500 | 3,600 |
| Net Income Continuous | -1,400 | -76,800 | 6,600 | -397,000 | 5,900 |
| Net Income Discontinuous | N/A | N/A | N/A | -300 | -1,600 |
| Net Income | $-1,400 | $-76,800 | $6,600 | $-397,300 | $4,300 |
| EPS Basic Total Ops | -0.03 | -1.66 | 0.14 | -8.64 | 0.09 |
| EPS Basic Continuous Ops | -0.03 | -1.66 | 0.14 | -8.62 | 0.12 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.02 | -0.03 |
| EPS Diluted Total Ops | -0.03 | -1.66 | 0.14 | -8.64 | 0.09 |
| EPS Diluted Continuous Ops | -0.03 | -1.66 | 0.14 | -8.62 | 0.12 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.02 | -0.03 |
| EPS Diluted Before Non-Recurring Items | 0.22 | 0.17 | 0.26 | 0.43 | 0.36 |
| EBITDA(a) | $9,500 | $12,500 | $19,900 | $29,300 | $23,700 |